Overall, 63% (30/48) of BRCA mutation-related DCIS lesions were HIF-1α-positive, which was significantly different compared to non-BRCA mutation carriers (34%, 26/77). The gene discussed is HIF1A; the disease is ductal breast carcinoma in situ.